Douglas P. Zipes MD
Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IndianaDr. Douglas P. Zipes is Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, and Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology at Indiana University School of Medicine. He received his medical degree from Harvard Medical School and trained at Duke University Medical Center in medicine and cardiology. He joined Indiana University in 1970, became Distinguished Professor in 1994, and then Director of Cardiology (1995–2004).
Having published almost 1000 medical articles and 16 textbooks with multiple editions, Dr. Zipes is the recipient of numerous awards from the American Heart Association, the Heart Rhythm Society, the American College of Cardiology, and the European Society of Cardiology, among other professional societies and institutions.
He is past president of the American College of Cardiology and the Heart Rhythm Society, and past chair of the American Board of Internal Medicine. He is a fellow of the Heart Rhythm Society, American Heart Association, European Society of Cardiology. He is Master of the American College of Physicians and American College of Cardiology, and he is a member of the American Society for Clinical Investigation and the Association of American Physicians. In addition, Dr. Zipes retains honorary membership in the Cardiac Society of Australia and New Zealand, Argentine Society of Cardiology, Hungarian Society of Cardiology, and Israel Heart Society.
Recent Contributions to PracticeUpdate:
- Baroreflex Dysfunction
- Wireless, Battery-Free, Implantable Pacemakers for Applications in Small Animal Models
- Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders
- 2019 Top Stories in Cardiology: Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial
- An Electrocardiographic Risk Score Predicts Sudden Cardiac Death in a General Population
- AHA Scientific Sessions 2019: Recommendations From Dr. Douglas Zipes
- Advanced Echocardiographic Imaging for Prediction of SCD in Moderate and Severe Left Ventricular Systolic Function
- Mapping and Ablation of Ventricular Fibrillation Associated With Early Repolarization Syndrome
- Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices
- Catheter Ablation Is Associated With Mortality Benefit Over Medical Therapy for Atrial Fibrillation